Risk and benefit of proton pump inhibitor for patients undergoing anti-platelet therapy including clopidogrel. Internal medicine (Tokyo, Japan) [Intern Med] Journal article
| Advertise on this site. | ||||||||||||||||||||
| |||||||||||||||||||||||||||||
Risk and benefit of proton pump inhibitor for patients undergoing anti-platelet therapy including clopidogrel. Internal medicine (Tokyo, Japan) [Intern Med] Journal article
| |||||||||||||||||||||||||||||